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Background
Obesity-related nonalcoholic fatty liver disease 
(NAFLD) is a worldwide health issue that can 
lead to liver fibrosis, cirrhosis, and failure 
resulting in premature death. Currently, over 90 
million people in the U.S. are thought to have 
NAFLD. Early detection and intervention are key 
to reverse the disease process. 
Newer imaging modalities such as the transient 
elastography (FibroScan) is a method in which 
healthcare providers can detect fibrosis and 
cirrhosis, as measured by the amount of liver 
stiffness, in individuals with NAFLD. The 
purpose of this review was to synthesize the 
literature comparing transient elastography 
(FibroScan) to invasive and noninvasive 
diagnostic techniques for the detection of liver 
fibrosis in people with non-alcoholic fatty liver 
disease. 
PICO Question
For patients with non-alcoholic fatty liver disease, 
does the use of transient elastography(FibroScan) 
reduce the instance of disease by early detection 
and management?
Figure 1. depicts the technique used to measure liver 
stiffness via transient elastography. [Reproduced 
from Rockey DC. Noninvasive assessment of liver 
fibrosis and portal hypertension with transient 
elastography. Gastroenterology 2008;134:8–14 with 
permission from Elsevier. Image from Kemp W, 
Roberts S. Feasibility and performance of the 
FibroScan XL probe. Hepatology
2012;55:1308–9]
Figure 2. displays examples of liver stiffness. 
[Reproduced from Castera L, Forns X, Alberti A. 
Non-invasive evaluation of liver fibrosis using 
transient elastography. J Hepatol 2008;48:835–
47 with permission from Elsevier. Image from 
Image from Kemp W, Roberts S. Feasibility and 
performance of the FibroScan XL probe. Hepatology
2012;55:1308–9]
Results
Overall, transient elastography (FibroScan) was 
found to be a sufficient tool in conjunction and 
comparison with invasive and noninvasive 
diagnostic techniques for the detection of liver 
fibrosis in people with non-alcoholic fatty liver 
disease.
Nursing Implications
Nurses can have a greater awareness of the 
tools used to detect liver stiffness which aides 
in the assessment and data collection for 
patients with NAFLD. Patient education is key 
to the prevention and maintenance of NAFLD.
Frameworks
Search terms used within this rapid systematic 
review included “transient elastography”, 
“Nonalcoholic fatty liver disease (NAFLD)” and 
“FibroScan”. Studies included in this review 
used transient elastography to detect fibrosis, 
cirrhosis and liver stiffness in individuals with 
NAFLD. 
Conclusions
New imaging such as transient elastography 
(FibroScan) has been used by healthcare 
providers to measure liver stiffness. Transient 
elastography was found to be a sufficient tool 
in the early detection and prevention of 
NAFLD. 
Methods & Design
Databases including PubMed, CINAHL, 
GoogleScholar and Web of Science were 
searched for studies published from 2008 to 
2019 for a comprehensive review. After 
reviewing abstracts, 30 articles met the 
inclusion criteria and were included in this 
review. 
